↓ Skip to main content

Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy

Overview of attention for article published in BMC Cancer, April 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

twitter
25 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy
Published in
BMC Cancer, April 2021
DOI 10.1186/s12885-021-08020-2
Pubmed ID
Authors

Glenn S. Bauman, Mark T. Corkum, Hatim Fakir, Timothy K. Nguyen, David A. Palma

X Demographics

X Demographics

The data shown below were collected from the profiles of 25 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 4 20%
Researcher 4 20%
Student > Bachelor 3 15%
Other 1 5%
Professor 1 5%
Other 1 5%
Unknown 6 30%
Readers by discipline Count As %
Medicine and Dentistry 10 50%
Biochemistry, Genetics and Molecular Biology 1 5%
Environmental Science 1 5%
Computer Science 1 5%
Nursing and Health Professions 1 5%
Other 0 0%
Unknown 6 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 January 2022.
All research outputs
#1,814,733
of 23,447,845 outputs
Outputs from BMC Cancer
#276
of 8,477 outputs
Outputs of similar age
#49,320
of 436,453 outputs
Outputs of similar age from BMC Cancer
#6
of 318 outputs
Altmetric has tracked 23,447,845 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,477 research outputs from this source. They receive a mean Attention Score of 4.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,453 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 318 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.